October 3, 2010

Lawsuits, Just the Cost of Criminal Marketing of Antipsychotic Drugs

A New York Times report (below) reviews what has been accomplished by multiple civil and criminal lawsuits

Read More
Lawsuits, Just the Cost of Criminal Marketing of Antipsychotic Drugs

September 2, 2010

Child’s Ordeal Shows Risks of Antipsychotic Drugs for Young

A “must read” front page article by New York Times reporter, Duff Wilson, “Child’s Ordeal Shows Risks

Read More
Child’s Ordeal Shows Risks of Antipsychotic Drugs for Young

August 23, 2010

Making a Killing–Marketing Exercises by Dr. Carl Elliott

Kudos to Carl Elliott, MD, PhD,  whose powerful article, “Making a Killing,” published in Mother Jones, is

Read More
Making a Killing–Marketing Exercises by Dr. Carl Elliott

April 8, 2010

In Medicine, the Power of No vs. Psychiatry’s Mass Overtreatment

New York Times columnist, David Leonhardt, applauds the new Medicare policy inaugurating comparative risk/ benefit analyses of

Read More
In Medicine, the Power of No vs. Psychiatry’s Mass Overtreatment

March 23, 2010

“Psychosis Risk Syndrome”– Psychiatry’s Hunting License

Following the acknowledgement reported by The New York Times (Feb. 10, 2010), that "Studies of teenagers identified

Read More
“Psychosis Risk Syndrome”– Psychiatry’s Hunting License

February 10, 2010

DSM5 Revisions

A report in the New York Times "Revising Book on Disorders of the Mind" by Benedict Carey

Read More
DSM5 Revisions

October 28, 2009

Nursing Homes: Psychotropic Drug Abuse

In the second half of the twentieth century, Soviet psychiatrists collaborated with their government: Soviet psychiatrists prescribed

Read More
Nursing Homes: Psychotropic Drug Abuse

August 16, 2009

FDA Approves Another Dangerous Antipsychotic, Asenapine

The FDA has approved Schering Plough’s new antipsychotic, asenapine (Saphris), for the treatment of schizophrenia and mania

Read More
FDA Approves Another Dangerous Antipsychotic, Asenapine

June 9, 2009

Did FDA Include Evidence of Brain Damage Caused by Antipsychotics?

The new generation antipsychotic drugs were all approved without proof of efficacy–they were approved to treat psychosis

Read More
Did FDA Include Evidence of Brain Damage Caused by Antipsychotics?

June 7, 2009

Is FDA Bipolar or Complicit in Legitimizing Illegal Marketing?

FDA officials are ignoring the real world tragedies–drug-induced deaths of children. Unfortunately for the children, child psychiatrists

Read More
Is FDA Bipolar or Complicit in Legitimizing Illegal Marketing?

March 10, 2009

Two Cases of Massive Fraud–Anesthesiology–Psychiatry

CASE 1. Anesthesiology News reports (below) that a leading anesthesiology researcher, Scott S. Reuben, MD, Director, Acute

Read More
Two Cases of Massive Fraud–Anesthesiology–Psychiatry

February 28, 2009

ADHD Drugs Induce Hallucinations in Kids–FDA safety Officers

The review included 49 randomized, controlled clinical trials in the pediatric development programs, as well as postmarketing

Read More
ADHD Drugs Induce Hallucinations in Kids–FDA safety Officers

February 19, 2009

Deaths, A Consequence of Forced Psychotropic Drugs

An obituary in The Boston Globe (below) reports that Ruby Rogers, the lead plaintiff in a landmark

Read More
Deaths, A Consequence of Forced Psychotropic Drugs

November 30, 2007

Letter of Complaint to FDA Commissioner, 2007

                                 ALLIANCE FOR HUMAN RESEARCH PROTECTION   www.ahrp.org 142 West End Avenue, Suite 28P New York, NY

Read More
Letter of Complaint to FDA Commissioner, 2007